Example: Heart Attack
Clinical Trials on Glabellar Crease
Total 10000 results
-
NCT03018080CompletedMale Breast Cancer | Breast - Female
-
NCT01487954CompletedStage I Breast Cancer | Radiation Toxicity | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer
-
NCT07340541RecruitingBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Estrogen-receptor-positive Breast Cancer | Hormone Receptor Negative Breast Carcinoma
-
NCT07002177RecruitingMetastatic Breast Cancer | Breast Cancer Stage I | Breast Cancer Stage II | ER+ Breast Cancer | Locally Advanced Breast Cancer (LABC)
-
NCT00194792TerminatedStage I Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast Cancer
-
NCT00516243CompletedStage I Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer
-
NCT00077376CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Recurrent Breast Cancer
-
NCT00039455TerminatedHER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Recurrent Breast Cancer
-
NCT01108016CompletedDepression | Breast Cancer | Stress | Breast Cancer Non-invasive Breast Cancer | Breast Cancer Early Stage Breast Cancer (Stage 1-3) | Breast Cancer Metastatic Breast Cancer
-
NCT06246968RecruitingBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | Breast Cancer Stage IV | Locally Advanced Breast Cancer | Metastatic Triple-Negative Breast Carcinoma | Locally Advanced Triple-Negative Breast Carcinoma
-
NCT02488967Active, not recruitingStage IIIA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Breast Adenocarcinoma
-
-
NCT02269670TerminatedStage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast Cancer
-
NCT01245205CompletedUnspecified Adult Solid Tumor, Protocol Specific | HER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer
-
NCT02445391Active, not recruitingStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Invasive Breast Carcinoma | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative
-
NCT01113554CompletedStage I Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer
-
NCT06324240RecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8
-
NCT01849250CompletedStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Invasive Breast Carcinoma | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Lobular Breast Carcinoma In Situ | Ductal Breast Carcinoma In Situ
-
NCT02515110Active, not recruitingBreast Cancer | Invasive Breast Carcinoma | Lobular Breast Carcinoma In Situ | Breast Adenocarcinoma | Node-positive Breast Cancer
-
NCT06234488Active, not recruitingBreast Cancer | Breast Neoplasms | Breast Cancer Stage IV | Breast Adenocarcinoma | Breast Cancer Stage | Breast Cancer Invasive | Breast Cancer in Situ
-
NCT00861705CompletedTriple-Negative Breast Carcinoma | Male Breast Carcinoma | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIA Breast Cancer AJCC v7
-
NCT00005970CompletedHER2 Positive Breast Carcinoma | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIA Breast Cancer AJCC v7 | Breast Adenocarcinoma
-
-
NCT06351332TerminatedBreast Cancer | Triple Negative Breast Cancer | Breast Cancer Female | HER2-negative Breast Cancer | Hormone Receptor Negative Malignant Tumor Breast Triple
-
NCT00132002TerminatedMale Breast Cancer | Stage IV Breast Cancer | Recurrent Breast Cancer
-
NCT01628887TerminatedStage I Breast Cancer | Cancer Survivor | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer
-
NCT00024154CompletedMale Breast Cancer | Stage IV Breast Cancer | Recurrent Breast Cancer
-
NCT00098397CompletedMale Breast Cancer | Stage IV Breast Cancer | Recurrent Breast Cancer
-
NCT00017394CompletedMale Breast Cancer | Stage IV Breast Cancer | Recurrent Breast Cancer
-
NCT05071677CompletedAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8
-
NCT07084571RecruitingBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer
-
NCT06342037Recruiting
-
NCT06225284RecruitingTriple Negative Breast Cancer | Premenopausal Breast Cancer
-
-
NCT05680662Not yet recruitingTriple Negative Breast Cancer | Breast Cancer Female
-
NCT05302778RecruitingBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer
-
NCT04891068RecruitingEarly-stage Breast Cancer | Breast Cancer Invasive | High Risk Breast Carcinoma
-
NCT04609215RecruitingBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer
-
NCT04699630CompletedMetastatic Breast Cancer | Locally Advanced Breast Cancer
-
NCT05826964Active, not recruitingBreast Cancer | Metastatic Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast Cancer
-
NCT03362060Active, not recruitingMetastatic Breast Cancer | Triple Negative Breast Cancer
-
NCT01837602CompletedMetastatic Breast Cancer | Triple Negative Breast Cancer
-
NCT03243331CompletedMetastatic Breast Cancer | Triple Negative Breast Cancer
-
NCT01204125Completed
-
NCT01176669CompletedMetastatic Breast Cancer
-
NCT01928680UnknownMetastatic Breast Cancer
-
NCT01045304Completed
-
NCT01819233CompletedStage IA Breast Cancer | Stage IB Breast Cancer | Recurrent Breast Cancer | Ductal Breast Carcinoma in Situ | Invasive Lobular Breast Carcinoma | Lobular Breast Carcinoma in Situ | Invasive Ductal Breast Carcinoma
-
NCT02314156CompletedStage 0 Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Lobular Breast Carcinoma In Situ | Ductal Breast Carcinoma In Situ | BRCA1 Mutation Carrier | BRCA2 Mutation Carrier
-
NCT01293032CompletedStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Ductal Breast Carcinoma in Situ | Lobular Breast Carcinoma in Situ
-
NCT06950671Not yet recruitingBreast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Stage III | Breast Cancer Invasive
-
NCT05508906RecruitingBreast Cancer | Metastatic Breast Cancer | Locally Advanced Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast Cancer